1. Greece Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
ATHENS MEDICAL CENTER S.A.

ATHENS MEDICAL CENTER S.A.

AATHEX:IATR
1.47
EUR
+0.02
(+1.38%)
64.97MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.64
1.72
1.82
1.93
1.95
2.11
2.27
2.16
2.61
2.69
2.98
3.11
3.18
- -
Basic EPS, GAAP
-0.45
-0.21
-0.18
0.04
0.03
0.12
0.09
0.05
0.17
0.08
0.09
0.02
-0.05
- -
Free Cash Flow per Basic Share
-0.42
0.04
0.15
0.11
-0.02
0.23
0.18
0.38
0.05
-0.18
0.04
0.23
-0.14
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.02
- -
- -
Book Value per Share
1.07
0.85
0.68
0.7
0.73
0.83
0.91
1
1.18
1.19
1.25
1.25
1.2
0.69
Tangible Book Value per Share
1.07
0.84
0.67
0.7
0.72
0.82
0.9
0.99
1.17
1.18
1.22
1.18
1.11
0.69
Basic Weighted Avg Shares
87
87
87
87
87
87
87
87
87
87
87
87
87
87
Sales/Revenue/Turnover
142
149
158
167
169
183
197
188
226
233
258
270
276
- -
Operating Margin (%)
-16.7
-6.46
-5.17
6.86
5.94
7.29
6.94
3.85
9.12
7.14
8.03
4.45
1.41
- -
Depreciation Expense
9
9
9
8
9
8
11
12
13
14
15
17
19
- -
Net Income, GAAP
-39
-19
-16
3
3
11
8
4
15
7
8
2
-5
- -
Effective Tax Rate (%)
- -
- -
- -
47.82
53.67
- -
28.79
32.79
21.51
35.44
40.44
58.08
- -
- -
Profit Margin (%)
-27.16
-12.47
-9.98
2.07
1.55
5.89
3.85
2.09
6.66
2.93
3.13
0.66
-1.69
- -
Working Capital
-132
-143
-147
-137
-129
-13
-125
-70
28
14
-3
-39
-68
-142
LT Debt
- -
- -
- -
- -
- -
111
11
40
129
121
102
84
76
- -
Total Equity
93
74
59
61
63
72
79
87
102
103
109
109
104
60
Return on Invested Capital (%)
- -
- -
- -
4.93
3.82
- -
6.9
3.36
7.8
5.7
6.46
2.93
- -
- -
Return on Capital (%)
- -
- -
- -
3.73
2.97
- -
5.7
3.51
8.17
4.68
5.27
2.35
- -
- -
Return on Common Equity (%)
-34.39
-22.33
-23.84
5.81
4.24
15.97
10.07
4.72
15.92
6.67
7.63
1.64
-4.4
- -

Capital Structure

EUR

•

in mil. unless spec.
Sep'15
Dec'15
Jun'16
ST Debt
151
149
148
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
87
87
87
Market Capitalization
60
53
65

Working Capital

EUR

•

in mil. unless spec.
Sep'15
Dec'15
Jun'16
Total Current Assets
130
124
131
Cash, Cash Equivalents & STI
3
10
5
Accounts Receivable, Net
85
78
90
Inventories
5
5
4
Total Current Liabilities
278
271
274
Payables & Accruals
- -
- -
- -
ST Debt
151
149
148
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.05%
3.91%
-4.37%
Free Cash Flow
-185.77%
-79.73%
-159.7%
Net Income, GAAP
-10.77%
-38.68%
-362.51%
Sales/Revenue/Turnover
5.91%
8.23%
2.19%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
258
2024
- -
- -
270
2025
- -
- -
276

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.09
2024
- -
- -
0.02
2025
- -
- -
-0.05

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
0.02
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Vasilios Georgios Apostolopoulos
Full Time Employees
3,499
Sector
Health services
Industry
Hospital/Nursing management
Address
5-7 Distomou Street Athens GI Greece 15125
IPO Date
Aug 29, 1991
Website
iatriko.gr
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Athens Medical C.S.A. (IATR.AT), operating as Athens Medical Group, provides integrated primary and secondary healthcare services through a network of eight hospitals in Greece equipped with 1,200 beds, 2,800 affiliated physicians, and 3,000 employees; core offerings encompass advanced diagnosis and treatment in interventional cardiology, electrophysiology, pediatric cardiology, cardiac surgery, robotic surgery in general, gynecologic, and urology fields, neuro- and spine surgery, oncology including prostate, bladder, kidney, and testicular cancer, orthopedics covering foot and ankle, hand and wrist, hip, knee, shoulder, and spine conditions as well as sports injuries, plastic and reconstructive surgeries for face, body, breast, obesity, scars, and sex reassignment, bariatric procedures such as gastric banding, sleeve gastrectomy, and biliopancreatic diversion, alongside management of preventive, lifestyle-related, and chronic diseases like diabetes, endocrinology, heart failure, hypertension, pain, respiratory issues, stroke, and thyroid disorders. The company, founded in 1984 and headquartered at 5-7 Distomou Street, Marousi, Greece, serves patients domestically and internationally with a patient-centered approach emphasizing multidisciplinary care for critical illnesses and educational programs tied to its clinical practices. Recent developments include changes to the board of directors and senior management composition following the 2025 annual general meeting in July, appointment of audit committee members and special negotiators in 2025, and release of the consolidated interim financial report for the first half of 2025 in September.